Shots:

• STADA to acquire GSK’s 15 well-established consumer healthcare brands including Venoruton- for venous treatment- Coldrex cold remedy- Cetebe vitamin C supplements- Mebucaine sore throat range and Tavegyl allergy brand
• The acquisition will strengthen STADA’s OTC portfolio and accelerates its growth in European countries. The transaction is expected to be completed in Q2’2020
• The acquisition follows STADA’s acquisition of GSK’s five OTC skincare brands-Ceridal- Eurax- Oilatum- Polytar- Savlon and pediatric cough remedies- Tixylix in EU and selected markets in the Asia-Pacific and Latin America regions

Click here ­to­ read full press release/ article 

Ref: STADA | Image: GSK